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INTRODUCTION
The incidence of endometrial carcinoma in Korea has in-
creased rapidly in the last ten years possibly due to an increas-
ingly westernized life style, decreased number of pregnancy,
and increase of postmenopausal hormone therapy (1). Surgery
is the treatment of choice and total hysterectomy with bilat-
eral salpingo-oophorectomy is the cornerstone of both the
staging and treatment of endometrial carcinoma. However,
although the International Federation of Gynecology and
Obstetrics (FIGO) adopted surgical staging in 1988, and
the National Comprehensive Cancer Network (2) also rec-
ommended standard surgical procedures, there is a signifi-
cant variety in the actual surgical procedures employed in
the treatment of patients with endometrial cancer. The man-
agement of patients with cervical involvement remains con-
troversial and treatment options range from extrafascial hys-
terectomy (EH) to radical hysterectomy (RH), with or with-
out radiation (3, 4). However, the literature regarding the
treatment of these patients is limited by its low frequency. 
Cervical extension of endometrial carcinoma represents
about 10% to 15% of cases at the time of diagnosis (5). Such
cervical invasion is considered to increase the risk of nodal
metastasis; and those patients are reported to have a worse
prognosis than those without it (6-9). The rationale for per-
forming RH in patients with cervical involvement is to erad-
icate all possible parametrial involvement (PMI). However,
the preoperative detection of cervical involvement or para-
metrial disease is not entirely reliable despite the progress
in imaging techniques such as magnetic resonance imaging
(10, 11). Thus, although the only definitive method of ensur-
ing the status and extent of disease in the parametria is through
radical excision and a histological study of the operative speci-
men, the unreliability of preoperative prediction, and the
relative rarity of PMI may make it unwise to resort to RH
as a matter of routine in patients with cervical invasion (12). 
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Necessity of Radical Hysterectomy for Endometrial Cancer Patients
with Cervical Invasion 
To determine whether radical hysterectomy is necessary in the treatment of endome-
trial cancer patients with cervical involvement, we reviewed the medical records of
women who underwent primary surgical treatment for endometrial carcinoma and
selected patients with pathologically proven cervical invasion. Among 133 patients,
62 patients underwent extrafascial hysterectomy (EH) and 71 radical or modified
radical hysterectomy (RH). The decision regarding EH or RH was made at the discre-
tion of the attending surgeon. The sensitivity of pre-operative magnetic resonance
imaging for cervical invasion was 44.7% (38/85). In RH patients, 10/71 (14.1%) pati-
ents had frankly histologic parametrial involvement (PMI). All were stage III or over.
Eight of 10 patients had pelvic/paraaortic node metastasis and two showed extrauter-
ine spread. In 74 patients with stage II cancer, RH was performed in 41 and PMI
was not seen. Sixty-six (89.2%) patients had adjuvant radiation therapy and there
were 3 patients who had developed recurrent disease in the RH group and none
in the EH group (Mean follow-up: 51 months). Although these findings cannot con-
clusively refute or support the necessity of radical hysterectomy in patients with cer-
vical extension, it is noteworthy that the risk of PMI seems to be minimal in patients
with a tumor confined to the uterus without evidence of extrauterine spread.
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We reviewed the medical records of endometrial cancer
patients with cervical involvement to determine the relation
of parametrial spread with other histopathological variables
and to evaluate whether the type of primary surgery using
EH or RH alters the patients’ outcome from a histological
perspective.
MATERIALS AND METHODS
The cancer database from five different institutes were re-
viewed; patients surgically diagnosed with stage II and a part
of stage III or IVa endometrial cancer with cervical involve-
ment during the period of 1993-2005 were identified. The
recorded data were then extracted by a medically qualified
gynecology trainee in each institute. The original pathology
reports and operation reports of 133 patients were reviewed
for the following information: age at diagnosis, pre-operative
data, operative procedure, adjuvant treatment, follow-up data
including date of recurrence, the patient status at last visit.
A pathologic data such as FIGO stage, histologic type, tumor
grade, depth of myometrial invasion, and the status of para-
metrium, and retroperitoneal lymph node were also reviewed.
Patients with mixed Mu_llerian tumor, including carcinosar-
coma or endometrial stromal sarcoma, were excluded from
the review. When the tumor grade varied between pre-oper-
ative biopsy and final pathologic reports, the higher grade
was recorded.
All surgeries were performed by board-certified gynecologic
oncologists. Confirmation of cervical invasion and staging
was made by reviewing pathology reports, although pathol-
ogy slides review was not performed. The term ‘Radical hys-
terectomy’ included modified hysterectomy (MRH) that could
not be exactly differentiated in operating records. 
Patients with surgically staged IIa cancer who had under-
gone EH were selectively treated with adjuvant radiation
according to the degree of depth of myometrial invasion. Oth-
erwise, most patients with stage IIb disease or above under-
went post-operative pelvic irradiation or brachytherapy. If
sufficient follow-up information regarding survival and recur-
rence was unavailable through medical records, we referred
to death certificates to obtain the required information. 
Statistical analysis was performed using SPSS version 12.0
(SPSS, Inc., Chicago, IL, USA). Logistic regression analysis
was done to identify the risk factors of PMI. We finally ana-
lyzed the follow-up results including the recurrence rates of
patients.
RESULTS
One hundred thirty-three patients with endometrial cancer
stage IIa to IVa were found to have cervical invasion. Patients’
characteristics are summarized in Table 1. Sixty two women
underwent EH and 71 underwent RH or MRH. Ninety-three
percent (124/133) of the patients underwent complete sur-
gical staging with or without paraaortic lymph node dissec-
tion. We found no significant difference in age, body mass
index (BMI), distribution of FIGO stage, histology, and tumor
grade between the EH and RH groups. 
Preoperative evaluations for disease extent including cer-
vical involvement were mostly done by magnetic resonance
imaging (MRI) and partly by computed tomography (CT)
or endocervical curettage. Pre-operative MRI was performed
in 63.9% (85/133) of the patients and sensitivity for cervical
invasion was 44.7% (38/85). When the cases with stromal
invasion were analyzed, the sensitivity was 53.3% (24/45). 
Table 2 presents the data for the choice of the extent of hys-
terectomy according to the results of preoperative evaluation.
EH was performed in 12/62 (19.4%) patients who were pre-
operatively suspected of cervical involvement, and more than
half (37/71, 52.1%) of the patients who underwent RH had
no preoperative evidence of cervical invasion. The results show
that many surgeons did not strictly follow the results of pre-
operative evaluation in choosing the type of hysterectomy and
the decision regarding EH or RH was made at their own dis-
cretion.
*P value for Fischer’s exact test or liner trend; 
� includes adenosquamous
type; 
� Most cases were non-endometrioid histology.
EH, extrafascial hysterectomy; RH, radical hysterectomy; NA, not avail-
able; ns, not significant.
Patient 
characteristics
Total
(n=133)
EH 
(n=62)
RH
(n=71)
P
value*
Median age 52 (31-78) 51.4 52.7 0.694
FIGO stage 0.835
IIa 22 9 13
IIb 52 24 28
IIIa 18 11 7
IIIb 2 2 0
IIIc 34 15 19
IV 5 1 4
Histology 0.667
Endometrioid
� 107 51 56
Non-endometrioid 26 11 15
Mixed 9 4 5
Clear cell 6 2 4
Papillary serous 8 2 6
Others 3 3 0
Tumor grade 0.061
G1 29 17 12
G2 47 25 22
G3 27 14 13
NA
� 30 16 14
Myometrial invasion 0.728
<50% 56 25 31
≥50% 77 37 40
Table 1. Characteristics of 133 patients with endometrial cancer
involving the cervix according to type of hysterectomy554 T.S. Lee, J.W. Kim, D.Y. Kim, et al.
Fig. 1 shows the relationship between the depth of myome-
trial invasion and that of cervical stromal invasion. A total
of 121 cases had available information about both about the
depth of myometrial and presence of cervical stromal inva-
sion. In patients with disease limited to the endometrium,
no case showed cervical stromal invasion. On the other hand,
a majority of patients with disease involving cervical stroma
had deep myometrial invasion (P=0.001). 
Table 3 showed the relationship between prognostic fac-
tors and parametrial involvement in 71 patients undergoing
RH. Ten patients (14.1%) had pathologic parametrial involve-
ment. All the patients with PMI were stage III or above. Eight
of ten patients (80.0%) had pelvic node metastasis, 1 patient
had grossly positive adnexal involvement, and 3 had tumor
spread outside the pelvis (2 of 3 had coexisting pelvic lymph
node metastasis). Depth of myometrial invasion and pelvic
or paraaortic lymph node positivity were significantly corre-
lated with paramatrial involvement. Of the 19 patients with
pelvic lymph node metastasis, 8 patients (42.1%) had con-
comitant PMI. Conversely, of the 10 patients with PMI, 8
(80.0%) had lymph node metastasis. 
In 74 patients with surgical stage II, i.e., disease showing no
demonstrable evidence of tumor spread in the pelvic cavity,
RH was performed in 41 cases and no patients showed para-
metrial involvement. Sixty six of 74 (89%) patients under-
went adjuvant radiation therapy (35 whole pelvic irradiation,
7 vaginal brachytherapy, 23 both, 1 unknown) and there were
3 patients who developed recurrent disease in the RH and
none in the EH group (mean follow-up: 51 months, Table 4).
*MRI, CT, and/or endocervical curettage. 
EH, extrafascial hysterectomy; RH, radical hysterectomy.
Type of hysterectomy EH (n=62) RH (n=71)
Pre-operative evaluation for  Positive (n=12) Negative (n=44) Unknown (n=6) Positive (n=32) Negative (n=37) Unknown (n=2)
cervical invasion*
Stage IIa 2 6 1 6 6 1
IIb 8 14 2 14 14 0
IIIa 1 9 1 1 6 0
IIIb 0 2 0 0 0 0
IIIc 1 12 2 8 10 1
I V 01 031 0
Table 2. Choice of the extent of hysterectomy according to the results of preoperative evaluation and final stage
Fig. 1. The relationship between the depth of myometrial invasion
and that of cervical stromal invasion showing a trend that myome-
trial invasion tends to precede cervical stromal invasion (P=0.001,
by chi-square test).
EM, endometrium; MM, myometrium.
%
80
70
60
50
40
30
20
10
0
Cervical glandular extension Cervical stromal invasion
(n=45) (n=76)
17
Confined to EM
8
<1/2 of MM
≥1/2 of MM
20
0
22
54
*P value for chi-square test or Fischer’s exact test.
PMI, parametrial involvement; ns, not significant; NA, not available; LN,
lymph node.
Overall
(n=71)
Factors
PMI
(n=10)
No PMI
(n=61)
P
value*
FIGO stage 0.001
IIa 13 0 13
IIb 28 0 28
IIIa 7 1 6
IIIb 0 0 0
IIIc 19 6 13
IV 4 3 1
Histology 0.677
Endometrioid 56 9 47
Non-endometrioid 15 1 14
Mixed 5 1 4
Clear cell 4 0 4
Papillary serous 6 0 6
Others 0 0 0
Tumor grade 0.573
G1 21 1 20
G2 22 4 18
G3 10 4 6
NA 3 1 2
Myometrial invasion 0.004
<50% 27 3 24
>50% 44 7 37
Pelvic/Paraaorrtic LN  0.001
Positive 19 8 11
Negative 46 0 46
NA 6 2 4
Table 3. Relationship between prognostic factors and parame-
trial involvement in 71 patients undergoing RHRadical Hysterectomy in Endometrial Cancer Patients with Cervical Invasion 555
DISCUSSION
Our results show that a large number of Korean gynecolog-
ic surgeons have a tendency to choose the surgical extent of
hysterectomy through their own disposition and do not strict-
ly adhere the results of pre-operative evaluation. Actually, the
type of hysterectomy procedure selected for endometrial can-
cer varies in each nation and in each institution. Watanabe
et al. (13) reported the results of a survey of a Japanese group
showing that more than 70% of institutes never perform RH
without regarding the preoperative status of cervical involve-
ment. Moreover, according to a survey in North America,
nearly 30% of centers never performed class II or III extend-
ed hysterectomy for the treatment of endometrial cancer (14).
As shown in Table 2, surgeons who overuse RH without re-
garding the pre-operative results may believe that the current
pre-operative evaluation method is not sensitive enough to
detect cervical invasion and thus, worry about possible PMI
or post-operative stump recurrence. On the other hand, those
who perform only EH despite the positive findings from pre-
operative evaluation may believe that cervical stromal inva-
sion should be followed by adjuvant radiotherapy and thus,
the prognosis would not be changed by performing a ‘high
morbidity producing surgery’ considering the low incidence
of PMI. This inconsistent treatment policy, in fact, necessi-
tates the need for an evidenced-based reformed guideline to
which most clinicians can conform, although the definition
of RH or EH is not standardized among surgeons and thus,
the actual extent of surgery investigated as RH or EH by med-
ical records might be different for each patient and this is one
of the limitations of this study. 
Our results also showed that the PMI rate in patients with
cervical invasion is about 14% in the RH group. This is with-
in the range reported by other investigators, and is not signif-
icantly lower than reported values (15-17). However, parame-
trial spread was not found in any of the patients with FIGO
stage II, i.e., patients showing no intraoperative tumor spread,
but was identified in 8 patients with positive pelvic lymph
nodes, and two showed grossly frank extrauterine spread around
the adnexa and another site in the pelvic cavity. 
These findings indicate that a risk of leaving an occult metas-
tasis in parametrial tissue when performing only EH in pa-
tients without evidence of extrauterine tumor spread seems
to be very low, even though all lymph node metastases may
not be completely screened by intraoperative frozen section.
In contrast to the present results, Yura et al. (17) report-
ed 11.5% of PMI in FIGO stage II patients. Although they
reported a relatively high rate of parametrial involvement,
the points we focused on is not the crude value of the PMI
itself, but the necessity of parametrial resection. Undoubt-
edly, cervical stromal invasion is known to increase the risk
of PMI. However, the pattern of spread in the invaded cervix
of endometrial cancer is quite different from that of primary
cervical carcinoma. As shown in Fig. 1, the pattern of cervi-
cal spread of endometrial cancer seems to follow myometrial
invasion and originate from the endocervical glandular region,
and as it advances, it invades the stroma. Therefore, we can
speculate that before the tumor of the endometrium reaches
the deep myometrium, a chance to detect direct PMI in the
patients with suspicious cervical invasion seems to be low. How-
ever, PMI in endometrial cancer cannot be completely exclud-
ed only by the absence of cervical stromal invasion because
PMI is reported to consist histologically of 2 patterns of spread:
direct invasion of cancer cells to the parametrial connective
tissues like that seen in cervical cancer, and parametrial lymph-
vascular space invasion frequently seen in patients with deep
myometrial involvement without cervical involvement (17-
19). Current guidelines for endometrial cancer show that cer-
vical stromal invasion is regarded as one of the major indica-
tions of adjuvant radiotherapy. We might guess that adjuvant
radiation is required due to the implication that cervical stro-
mal invasion raises the risk of recurrence not just by direct
PMI from the cervix, but also by increasing the risk of occult
parametrial involvement from the preceding deep myome-
trial invasion or myometrial lymph-vascular space invasion.
Suffice it to say, this suggest that performing RH only in
patients with cervical involvement cannot guarantee the com-
plete eradication of possible parametrial involvement. In addi-
tion, it is very likely that we may have ‘cut through’ the in-
vaded parametrium in stage II patients who underwent EH
even though it was not revealed by pathology because there
was no direct connection between the invaded cervical stro-
ma and parametrium itself. Even acknowledging that occult
parametrial spread had existed, our data showed that no recur-
*P value for t-test or Fischer’s exact test. 
DFI, disease free interval.
Extrafascial 
hysterectomy (n=33)
Total (n=74) Clinical features
Modified radical 
hysterectomy (n=41)
P
value*
Endometrioid (%) 62 (83.8) 28 (84.8) 34 (82.9) 1.000
Follow-up (months) 50.66 52.9 51.7 0.868
Adjuvant radiation (%) 66 (89.2) 26 (78.8) 40 (97.6) 0.019
Recurrence 3 0 3 0.124
Mean DFI (months) 50.7 52.9 49.2 0.875
Table 4. Clinical follow-up features of 74 stage II patients by surgical procedure556 T.S. Lee, J.W. Kim, D.Y. Kim, et al.
rences occurred in patients who only underwent EH followed
by adjuvant radiation and thus, it suggests that occult parame-
trial metastasis in patients with no gross extrauterine spread
can be successfully controlled by radiation therapy. 
We could not evaluate the value of RH in patients with
stage III or over because their survival outcome is much likely
to be influenced by variables other than parametrial involve-
ment, i.e., lymph node status, extent of tumor spread, differ-
ent treatment strategy to the recurred patients, etc. We did
not overcome the limitations of retrospective analysis, i.e.,
lack of verifying the actually performed surgical extent, lack
of centralization of pathologic review, and limited number of
cases. Nonetheless, we cautiously suggest that routine RH in
patients with cervical invasion and having no grossly positive
extrauterine spread should be reappraised and that these pati-
ents are worthy of consideration for less radical surgery per-
formed in conjunction with pelvic and paraaortic lympha-
denectomy considering the low rate of parametrial involve-
ment, inaccurate preoperative prediction, high post operative
morbidity, and successful control through adjuvant radiation.
Since this is an area of continued debate and a principal
shift from our current practice and attitudes, a randomized
study would be required to define the low-risk population
that would have a modification of the extent of parametrial
resection performed. In this regards, we can conclude that
the real value of RH in endometrial cancer patients with sus-
picious cervical involvement can be evaluated by performing
a large scaled randomized controlled study comparing the sur-
vival and quality of life between the group who underwent
RH only or followed by tailored adjuvant radiation and the
group with EH and routine adjuvant radiation therapy. 
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